Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
基本信息
- 批准号:8051862
- 负责人:
- 金额:$ 38.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-15 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Oxidative stress resulting from environmental exposures is associated with a variety of human diseases ranging from chemical teratogenesis to cardiovascular and neurodegenerative diseases. Developing animals appear to be especially sensitive to chemicals causing oxidative stress. The expression and inducibility of anti-oxidant defenses are critical factors affecting susceptibility to oxidants at these early life stages, but the ontogenic development of these responses in embryos is not well understood. In adult animals, oxidants initiate an anti-oxidant response by activating NF-E2-related factor 2 (NRF2) and related proteins, which bind to the anti-oxidant response element and activate transcription of genes such as glutathione S-transferases, NAD(P)H-quinone oxidoreductase, glutamyl-cysteine ligase, and superoxide dismutase. The overall objective of the research proposed here is to elucidate the mechanisms by which vertebrate embryos respond to oxidative stress during development. We will test the central hypothesis that responsiveness to oxidative stress and the set of regulated genes vary during development. Because of these developmental differences, some stages may be more sensitive to oxidative stress-induced damage. These studies will be performed in vivo using embryos of the zebrafish (Danio rerio), a valuable model in which to examine mechanisms of toxicity in developing animals and to screen chemicals for developmental toxicity. Aim 1 will use transcriptional profiling and phenotypic anchoring to identify the core set of genes that comprise the oxidative stress response in embryos, establish how the responsiveness and composition of the core set of oxidant-responsive genes vary with developmental stage of embryos, and determine how the timing and gene profile of the oxidative stress response differ in embryos exposed to structurally and mechanistically distinct activators of NRF2 (tBHQ, diquat, sulforaphane). Aim 2 will elucidate the roles of different NRF paralogs in the transcriptional response to oxidative stress during development in embryos in vivo, using targeted knock-down of NRF protein synthesis with morpholino oligonucleotides. Aim 3 will establish the mechanism of regulation of anti-oxidant response genes during embryonic development through computational and in vivo experimental analysis of oxidant-responsive gene promoters, leading to the generation of a stable line of transgenic zebrafish expressing a reporter gene (GFP) in response to oxidative stress. Finally, we will test a set of mammalian developmental toxicants for the ability to activate the transgene in embryos. The results of these studies will establish the composition and ontogeny of the transcriptional response to oxidative stress in vertebrate embryos, elucidate fundamental mechanisms underlying this response, generate tools for screening chemicals for activity as developmental toxicants or antioxidants, and provide insight into the role of oxidative stress in human disease. PUBLIC HEALTH RELEVANCE: Oxidative stress is involved in a variety of environmentally influenced human diseases ranging from chemical teratogenesis to cardiovascular and neurodegenerative diseases. The proposed research will enhance our basic understanding of how some chemicals interfere with embryonic development by generating oxidative stress and how embryos can mitigate these effects. This research will i) determine the basal expression and inducibility of anti-oxidant defenses during embryonic development, ii) elucidate fundamental mechanisms of the response of vertebrate embryos to oxidative stress, iii) establish a model system for screening chemicals for activity as developmental toxicants or antioxidants, and iv) provide a mechanistic foundation that will facilitate the extrapolation of results obtained in zebrafish to humans, supporting risk assessment and providing insight into the role of oxidative stress in human disease.
描述(由申请人提供):环境暴露引起的氧化应激与各种人类疾病有关,范围从化学畸胎发生到心血管和神经退行性疾病。发育中的动物似乎对引起氧化应激的化学物质特别敏感。抗氧化剂防御措施的表达和诱导性是影响这些早期生命阶段氧化剂易感性的关键因素,但是对胚胎中这些反应的个体发育尚不清楚。在成年动物中,氧化剂通过激活NF-E2相关因子2(NRF2)和相关蛋白质引发抗氧化剂反应,该因子与抗氧化剂反应元件结合并激活基因的转录,例如谷胱甘肽S-转移酶,NAD(P)H- Quinone氧化氧化物酶酶酶,粘液氨基氨基酶ligasase ligasase,and ligase ligasase stase stase stase stase stase&procrets ult and suprart and ult and and suprart and ult and。此处提出的研究的总体目的是阐明脊椎动物胚胎在发育过程中对氧化应激反应的机制。我们将检验一个中心假设,即对氧化应激的反应性和在发育过程中的受调节基因集有所不同。由于这些发育差异,某些阶段可能对氧化应激引起的损伤更敏感。这些研究将使用斑马鱼(Danio Rerio)的胚胎在体内进行,这是一个有价值的模型,其中旨在检查发育中动物中毒性的机制,并筛选出化学物质的发育毒性。 AIM 1将使用转录分析和表型锚定来识别构成胚胎中氧化应激反应的核心基因集,并确定氧化剂反应基因的核心核心集合和组成如何随胚胎的发育阶段而变化,并确定在嵌入型氧化应激术中的敏感性和基因在结构上的敏感性和基因的结构敏感性和基因的结构性响应方式以及结构性的机制差异。 (TBHQ,Diquat,Sulforaphane)。 AIM 2使用靶向敲击NRF蛋白质合成与morpholino寡核苷酸的靶向敲击,将阐明不同NRF旁系同源物在体内发育过程中对氧化应激的转录反应中的作用。 AIM 3将通过计算和体内实验分析对氧化剂反应性基因启动子进行调节抗氧化反应基因的调节机制,从而导致产生稳定的转基因斑马鱼,表达对氧化应激的响应,表达报告基因的基因(GFP)。最后,我们将测试一组哺乳动物发育毒物,以便激活胚胎中的转基因的能力。这些研究的结果将建立脊椎动物胚胎中对氧化应激的转录反应的组成和个体,阐明了这种反应的基本机制,生成了用于筛选化学物质作为发育毒理或抗氧化剂的化学物质的工具,并为氧化应激在人类疾病中的作用提供了洞察力。公共卫生相关性:氧化应激与各种受环境影响的人类疾病有关,从化学致畸作用到心血管和神经退行性疾病。拟议的研究将增强我们对某些化学物质如何通过产生氧化应激以及胚胎如何减轻这些作用来干扰胚胎发育的基本理解。这项研究将i)确定在胚胎发育过程中抗氧化剂防御的基础表达和诱导性,ii)阐明脊椎动物胚胎对氧化应激的反应的基本机制,iii)建立一种筛选化学物质的模型系统,用于将化学物质作为发育毒性或抗氧化剂的发展,并为统一的基础提供了范围,以使其对统一的基础,以使范围内的基础构成范围的范围,并构成了范围内的范围。风险评估并提供有关氧化应激在人类疾病中的作用的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Mark E Hahn的其他基金
Understanding the origins and mechanisms of aryl hydrocarbon receptor promiscuity
了解芳烃受体混杂的起源和机制
- 批准号:1067953210679532
- 财政年份:2023
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Mechanisms Controlling Sensitivity and Resistance to Dioxin-like Compounds: Role of AIP
控制对二恶英类化合物的敏感性和耐受性的机制:AIP 的作用
- 批准号:1053894310538943
- 财政年份:2022
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Gene-by-environment interactions that affect exposure-mediated congenital heart disease
影响暴露介导的先天性心脏病的基因与环境相互作用
- 批准号:1021646310216463
- 财政年份:2021
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Gene-by-environment interactions that affect exposure-mediated congenital heart disease
影响暴露介导的先天性心脏病的基因与环境相互作用
- 批准号:1065561110655611
- 财政年份:2021
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Project 3: Cellular and Molecular Mechanisms Underlying Long-term Effects of Early Life Exposure to HAB Toxins
项目 3:生命早期接触 HAB 毒素造成长期影响的细胞和分子机制
- 批准号:1043478310434783
- 财政年份:2018
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Project 3: Cellular and Molecular Mechanisms Underlying Long-term Effects of Early Life Exposure to HAB Toxins
项目 3:生命早期接触 HAB 毒素造成长期影响的细胞和分子机制
- 批准号:1022330910223309
- 财政年份:2018
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
microRNAs in Developmental Toxicology
发育毒理学中的 microRNA
- 批准号:76429737642973
- 财政年份:2009
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
- 批准号:82445248244524
- 财政年份:2009
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
- 批准号:84501758450175
- 财政年份:2009
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
- 批准号:76551107655110
- 财政年份:2009
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
相似国自然基金
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于基因组数据自动化分析为后生动物类群大规模开发扩增子捕获探针的实现
- 批准号:32370477
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
- 批准号:32371605
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
- 批准号:42306159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mitochondrial Calcium and Neuronal Health
线粒体钙和神经元健康
- 批准号:1063886910638869
- 财政年份:2023
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
- 批准号:1064301210643012
- 财政年份:2023
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Synergistically Target Mitochondria for Heart Failure Treatment
协同靶向线粒体治疗心力衰竭
- 批准号:1058493810584938
- 财政年份:2023
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Dual-Wavelength Blue Light Irradiation for Improved Treatment of Staphylococcus aureus Infections
双波长蓝光照射改善金黄色葡萄球菌感染的治疗
- 批准号:1072447610724476
- 财政年份:2023
- 资助金额:$ 38.07万$ 38.07万
- 项目类别:
Sex Effects for Hearing Loss Drug Therapies
性对听力损失药物治疗的影响
- 批准号:1079107610791076
- 财政年份:2023
- 资助金额:$ 38.07万$ 38.07万
- 项目类别: